Although sometimes portrayed in film and television as simply "falling asleep without warning," the reality of narcolepsy is ...

Narcolepsy is often mistaken for stress or laziness, but this rare disorder stems from a brain chemical deficiency doctors can now treat. Here's what to know.

Add Yahoo as a preferred source to see more of our stories on Google. Common symptoms of narcolepsy, including excessive daytime sleepiness, cataplexy (sudden loss of motor strength and tone), ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. Matthew Horsnell began ...

Geraldine Gruszczyk lives with narcolepsy with cataplexy, a disorder triggered by intense emotions. "The first time my body ...

Narcolepsy may be treated with several types of prescription medications. While often not the first choice of treatment due to safety concerns, gamma-hydroxybutyrate may be used in certain cases.

Add Yahoo as a preferred source to see more of our stories on Google. Narcolepsy is a condition that can have a huge psychological, social and physical impact on those who have it. It is characterised ...

It can take up to two years before a child gets an accurate narcolepsy diagnosis, often because the symptoms appear to be ...

A hormone produced by the brain, orexin, may play a central role in the functioning of the brain’s glymphatic system, which clears waste, according to a new study from the University of Oulu.

Everyone experiences occasional daytime sleepiness, but just a small fraction of the population knows what it’s like to have narcolepsy. The disorder is defined by persistent drowsiness throughout the ...

Type 1 narcolepsy is often more severe and includes cataplexy, which is sudden muscle weakness triggered by emotions. Both type 1 and type 2 narcolepsy cause excessive daytime sleepiness, but people ...

Blair Jackson says the next 12 months may be the most important in Alkermes’ history, as the brain drugmaker races to join an ...